Matthew Christopher

Medicine & Life Sciences

1. Granulocyte Colony-Stimulating Factor 100%
2. Hematopoietic Stem Cells 88%
3. Acute Myeloid Leukemia 72%
4. Osteoblasts 72%
5. Bone Marrow 53%
6. Hematopoietic Stem Cell Mobilization 41%
7. Granulocyte Colony-Stimulating Factor Receptors 38%
8. Mutation 33%
9. Myeloid Cells 33%
10. Chemokine CXCL12 27%
11. Leukemia 27%
12. Recurrence 25%
13. Transplantation 24%
14. Genome 22%
15. Cytogenetic Analysis 21%
16. Critical Pathways 21%
17. Homologous Transplantation 20%
18. Myelodysplastic Syndromes 20%
19. Toll-Like Receptors 20%
20. Karyotype 18%
21. Precursor Cell Lymphoblastic Leukemia-Lymphoma 18%
22. Neutrophils 17%
23. Stromal Cells 16%
24. Immunosuppression 16%
25. Methylation 16%
26. Whole Genome Sequencing 16%
27. Maintenance 15%
28. Prostate 15%
29. Cytokines 14%
30. Exome 13%
31. Homeostasis 13%
32. MHC Class II Genes 13%
33. Carcinoma 12%
34. Apoptosis 11%
35. flt3 ligand protein 11%
36. Therapeutics 10%
37. Heterografts 10%
38. Bone Marrow Cells 10%
39. Neoplasms 10%
40. Messenger RNA 10%
41. Integrin alpha4beta1 10%
42. Transgenic Mice 9%
43. Stem Cell Factor 8%
44. Transplants 8%
45. Unrelated Donors 8%
46. Gene Frequency 7%
47. RNA Sequence Analysis 7%
48. Down-Regulation 7%
49. Progression-Free Survival 7%
50. Drug Therapy 7%